A detailed history of Principal Securities, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Principal Securities, Inc. holds 7,826 shares of EXAS stock, worth $387,700. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,826
Previous 9,095 13.95%
Holding current value
$387,700
Previous $384 Million 38.73%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$42.43 - $70.83 $53,843 - $89,883
-1,269 Reduced 13.95%
7,826 $533 Million
Q2 2024

Jul 31, 2024

SELL
$41.33 - $74.26 $11,531 - $20,718
-279 Reduced 2.98%
9,095 $384 Million
Q1 2024

May 10, 2024

SELL
$56.27 - $73.77 $7,146 - $9,368
-127 Reduced 1.34%
9,374 $647 Million
Q4 2023

Feb 07, 2024

BUY
$59.06 - $75.72 $561,129 - $719,415
9,501 New
9,501 $703 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.77B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.